How Collagen Changes With Age — and What Hormones Have to Do With It

Originally published February 2026 · Updated May 2026 with the August 2025 Journal of Cosmetic Dermatology narrative review on HRT and skin collagen, the October 2025 European Medical Journal clinician's review on menopausal skin, and The Conversation May 2026 collagen cliff analysis

Women lose up to 30% of skin collagen in the first five years after menopause — a rate dramatically faster than the 1 to 2% annual loss of gradual ageing. A 2025 Journal of Cosmetic Dermatology review confirmed HRT promotes collagen synthesis. Here's what is actually happening and what genuinely helps.

Collagen is one of those words that has been so thoroughly absorbed by beauty marketing that its actual biology has become obscured. It is not simply a skincare ingredient. It is the most abundant protein in the human body — constituting approximately 30% of total body protein — and a structural component of skin, bone, cartilage, tendons, blood vessels, and gut tissue.

Its decline with age is real, consequential, and considerably more complex than most skincare marketing suggests. And its relationship with hormones — particularly oestrogen — is one of the most important and least discussed aspects of skin ageing in women, with implications that extend well beyond cosmetic concern.

TL;DR

• Collagen production declines gradually from the mid-20s at approximately 1 to 2% per year — an intrinsic ageing process affecting everyone.
• Women lose approximately 30% of their cutaneous collagen in the first five years post-menopause — a loss more closely correlated with the duration of oestrogen deficiency than with chronological age.
• Oestrogen directly regulates collagen production by acting on fibroblasts — the cells that synthesise collagen in the dermis. When oestrogen falls, fibroblast activity slows and collagen-degrading enzymes become more active simultaneously.
• A 2025 Journal of Cosmetic Dermatology narrative review confirmed that HRT enhances skin quality by promoting collagen synthesis, elasticity, and hydration. One trial demonstrated a 6.49% increase in skin collagen after six months of oral oestrogen.
• Collagen supplements have modest but consistent evidence for improving skin hydration and elasticity — primarily through providing hydroxyproline-proline dipeptides that stimulate fibroblast activity rather than through direct incorporation into skin collagen.

The most evidence-backed non-hormonal approach to collagen support combines daily SPF, topical vitamin C, dietary protein adequacy, and reduction of the specific dietary and lifestyle factors that accelerate collagen degradation.

What Collagen Is and Why It Matters

Collagen is a family of fibrous structural proteins — there are at least 28 types — with Type I and Type III being the most abundant in skin. In the dermis, collagen fibres form a scaffold that gives skin its structural integrity, firmness, and resistance to wrinkling. Elastin fibres — a separate protein — provide the springback quality. Together they determine the mechanical properties of skin.

Collagen is produced by fibroblasts in the dermis, in a process that requires vitamin C as a cofactor — without adequate vitamin C, the procollagen molecules that fibroblasts produce cannot be properly cross-linked into functional collagen fibres, explaining the skin changes seen in scurvy. Fibroblast collagen synthesis is also directly regulated by multiple hormonal signals — oestrogen and growth hormone most significantly — and modulated by mechanical signals from the extracellular matrix.

The dermis is approximately 75% collagen by dry weight. When collagen content declines significantly — whether through age, hormone deficiency, UV damage, or other factors — the structural scaffold of the dermis weakens, producing the characteristic changes of skin ageing: wrinkles, loss of firmness, reduced skin thickness, and impaired wound healing.

The Gradual Decline: Intrinsic Ageing

Intrinsic collagen decline begins earlier than most people realise. Collagen levels begin to decrease in the mid-20s — as does the quality of the collagen produced. The rate of this gradual intrinsic decline is approximately 1 to 2% per year, consistent across individuals regardless of gender or hormonal status.

This gradual decline produces subtle but cumulative effects over decades. Skin progressively thins, fine lines develop, and the skin's ability to recover from deformation slows. These changes are visible but gradual — easily confused with the effects of sun exposure, which occur simultaneously and often more dramatically.

The intrinsic decline is not primarily hormone-driven in its gradual phase — it reflects the accumulation of mitochondrial DNA damage in fibroblasts, reduced fibroblast proliferative capacity, and declining growth factor signalling that is a feature of cellular ageing generally. Both men and women experience this gradual decline at comparable rates.

The Hormonal Cliff: What Happens at Menopause

The gradual intrinsic decline is superimposed, in women, by a dramatically accelerated loss that coincides with the decline of oestrogen at perimenopause and menopause. This is where the collagen story for women diverges sharply from the gradual ageing process.

It is estimated that women lose approximately 30% of their cutaneous collagen in the first five years post-menopause — a loss more closely correlated with the duration of oestrogen deficiency than with chronological age.

To contextualise this: the gradual intrinsic decline produces approximately 5 to 10% collagen loss over five years. The oestrogen-deficiency-driven loss produces 30% over the same period. This is not a continuation of the gradual trend — it is a qualitative shift in the rate of collagen loss, driven by the specific biological role of oestrogen in fibroblast function.

Oestrogen acts on fibroblasts — the cells responsible for making collagen in the skin. When oestrogen levels fall during perimenopause and menopause, this signalling becomes weaker. The result is less collagen being produced, along with thinner skin, reduced elasticity and lower water content.

The acceleration occurs through two simultaneous processes. First, fibroblast collagen synthesis slows because the oestrogen signalling that drives it is reduced. Second, the matrix metalloproteinases — the enzymes that break down existing collagen — become more active in an oestrogen-deficient environment. More collagen is being destroyed and less is being made simultaneously, explaining the dramatic rate of loss in the early post-menopausal years.

Post-menopause, oestrogen remains low. When oestrogen falls, the signals that drive collagen production weaken. Fibroblast activity slows. At the same time, collagen-degrading enzymes in the skin become more active.

The collagen loss is not limited to skin. The same oestrogen-fibroblast relationship operates in bone — where it contributes to the accelerated bone density loss of the early post-menopausal years — and in the genitourinary tissues, joint cartilage, and intervertebral discs. The "collagen cliff" is a systemic phenomenon, not a cosmetic one.

What HRT Does to Collagen

The evidence for HRT's effects on skin collagen is consistent across multiple trials and has been reviewed comprehensively in 2025.

A 2025 Journal of Cosmetic Dermatology narrative review confirmed that HRT enhances skin quality by promoting collagen synthesis, elasticity, and hydration.

The specific trial evidence is striking. One randomised double-blind placebo-controlled trial demonstrated that one year of oral oestrogen therapy increased dermal thickness by 30% in postmenopausal women. A similar trial established that six months of treatment with oral oestrogen increases skin collagen by 6.49%. The increase in response to oestrogen therapy in skin collagen content appears to be related to the initial collagen content — in women with low skin collagen content, oestrogen is initially therapeutic, but later becomes purely prophylactic; in women with only mild collagen loss in the early years following menopause, the effect is essentially prophylactic.

This timing dependency is clinically important. Starting HRT early in the peri-menopausal transition — when collagen loss is beginning but has not yet been severe — produces both the benefit of slowing the loss and partially restoring what has already been lost. Starting HRT many years after menopause, when collagen loss has been sustained for a decade or more, is more likely to stabilise rather than reverse.

Although HRT appears to offer benefits for skin thickness, elasticity, and collagen when given near the onset of menopause, it is not currently indicated solely for treating oestrogen-deficient skin. HRT is prescribed for the full range of menopausal symptoms and health outcomes — vasomotor symptoms, bone density, cardiovascular health, cognitive function — and skin collagen preservation is an additional benefit rather than the primary indication.

Testosterone and Collagen

Testosterone's role in collagen is less discussed but relevant — particularly for the growing number of women prescribed testosterone as part of comprehensive hormone replacement.

Testosterone receptors are expressed in skin fibroblasts, and testosterone directly stimulates collagen synthesis through androgen receptor pathways. The relative androgenic dominance of the perimenopausal period — where oestrogen fluctuates dramatically while testosterone declines more gradually — means that some women experience a transitional period where testosterone's collagen-supporting effects partially compensate for declining oestrogen.

After menopause, testosterone levels also decline — more slowly than oestrogen, but significantly. Women prescribed testosterone alongside HRT frequently report improvements in skin quality that are attributed to testosterone's direct fibroblast effects alongside oestrogen's contributions.

Collagen Supplements: What the Evidence Shows

The collagen supplement market has grown dramatically alongside the broader collagen awareness in women's health. The evidence for oral collagen supplementation is more nuanced than most marketing suggests — and more supportive than the most sceptical position.

The central question for collagen supplements was whether orally consumed collagen peptides survive digestion and reach the skin in a form that stimulates collagen synthesis — or whether they are simply digested into amino acids and used as general protein.

The answer from the more recent research is: partially both, and the benefit is real but modest. Hydrolysed collagen supplements produce specific dipeptide fragments — particularly hydroxyproline-proline — that survive intestinal digestion, are absorbed into circulation, and reach skin fibroblasts, where they appear to act as signalling molecules that stimulate collagen synthesis. This is not the same as directly incorporating the supplement into skin collagen — it is a signalling effect.

Multiple randomised controlled trials have demonstrated improvements in skin hydration, elasticity, and wrinkle depth from hydrolysed collagen supplementation at 2.5 to 10g per day over 8 to 12 weeks. The effect sizes are modest — these are not dramatic transformations — but they are consistent across studies and biologically plausible.

The evidence is strongest for skin hydration and elasticity rather than dramatic wrinkle reduction. For women experiencing the accelerated collagen loss of the menopausal transition, collagen supplements may represent a useful complement to HRT and topical strategies — but they do not address the underlying hormonal driver of the accelerated loss.

What Accelerates Collagen Loss

Understanding the modifiable factors that accelerate collagen degradation beyond the intrinsic and hormonal processes is practically important — because several are within direct control.

UV radiation — the single most significant modifiable driver of collagen loss. UV exposure activates matrix metalloproteinases in the dermis, directly degrading collagen. A single UV exposure produces measurable MMP activation. Decades of cumulative UV exposure without SPF protection produces collagen loss that substantially compounds the intrinsic and hormonal losses.

Smoking — produces reactive oxygen species that directly damage collagen fibres and activates MMPs. Smokers consistently show significantly more facial wrinkling and skin thinning than age-matched non-smokers.

Excess sugar and ultra-processed food — advanced glycation end products (AGEs) form when glucose reacts with collagen proteins, producing cross-linked, stiff collagen that is structurally inferior and more resistant to natural turnover and repair. High dietary sugar intake accelerates this glycation process.

Alcohol — reduces vitamin A and vitamin C availability, both of which are required for normal collagen synthesis, and increases the oxidative stress that damages existing collagen.

Poor sleep — growth hormone — the primary signal for collagen synthesis and tissue repair — is released primarily during deep sleep. Chronic sleep deprivation reduces growth hormone secretion and impairs the nightly collagen repair process.

Chronic psychological stress — elevates cortisol, which directly suppresses collagen synthesis by reducing fibroblast activity and increasing MMP expression.

What Supports Collagen Synthesis

Daily broad-spectrum SPF — the most impactful single intervention for preventing further collagen loss from UV-driven MMP activation. Not negotiable as a foundation.

Topical vitamin C — directly supports collagen synthesis as a cofactor for proline hydroxylase and lysine hydroxylase — the enzymes that cross-link procollagen molecules into functional collagen fibres. Also scavenges the UV-generated ROS that activate MMPs. Evidence for both prevention and modest reversal of UV-driven collagen loss.

Retinoids — the most evidence-backed topical treatment for reversing collagen loss. Tretinoin and retinol stimulate fibroblast collagen synthesis and reduce MMP activity, producing measurable increases in dermal collagen density over months of consistent use.

Adequate dietary protein — collagen synthesis requires a continuous supply of amino acids, particularly glycine, proline, and hydroxyproline. Dietary protein deficiency impairs fibroblast collagen production. For most adults eating a varied diet, protein adequacy is sufficient — but for those on very low calorie or very low protein dietary patterns, inadequate amino acid availability limits collagen synthesis capacity.

Vitamin C from food — citrus fruits, berries, kiwi, peppers, and leafy greens provide the dietary vitamin C that is required for collagen synthesis throughout the body, not just in skin.

HRT at perimenopause — for women experiencing the accelerated collagen loss of the menopausal transition, HRT addresses the primary hormonal driver rather than compensating for it after the fact. The timing evidence suggests starting near the onset of perimenopause produces both therapeutic and prophylactic collagen benefits.

Frequently Asked Questions

Why do women lose so much collagen at menopause?

Oestrogen directly regulates fibroblast collagen production — it is a key signalling molecule for the cells that make collagen in the dermis. When oestrogen falls at menopause, fibroblast activity slows and collagen-degrading enzymes simultaneously become more active. The result is a dramatic acceleration in collagen loss — up to 30% in the first five years post-menopause — that is far faster than the 1 to 2% annual decline of gradual intrinsic ageing.

Does HRT help with collagen loss?

Yes — consistently across multiple trials. A 2025 Journal of Cosmetic Dermatology review confirmed HRT promotes collagen synthesis, skin elasticity, and hydration. One trial showed a 6.49% increase in skin collagen after six months of oral oestrogen, and another demonstrated 30% increased dermal thickness after one year. The benefits are greatest when HRT is started near the onset of perimenopause rather than many years after menopause.

Do collagen supplements actually work?

Modestly — yes. Hydrolysed collagen supplements at 2.5 to 10g per day produce specific dipeptide fragments that stimulate fibroblast collagen synthesis through a signalling mechanism. Multiple randomised trials show improvements in skin hydration and elasticity over 8 to 12 weeks. The effects are real but modest — they do not address the hormonal driver of accelerated menopausal collagen loss and are best used as a complement to other interventions rather than a primary strategy.

When does collagen start declining?

Gradual intrinsic collagen decline begins in the mid-20s at approximately 1 to 2% per year. This is a slow, cumulative process affecting both men and women. In women, this gradual decline is dramatically accelerated at perimenopause and menopause due to oestrogen's role in fibroblast regulation. The combined effect of intrinsic decline and hormonal acceleration produces the most significant visible skin changes of the 40s and 50s.

What is the most effective way to preserve collagen?

The highest-impact interventions are daily broad-spectrum SPF — preventing the UV-driven MMP activation that is the most significant modifiable driver of collagen loss — combined with topical retinoids that stimulate fibroblast collagen synthesis. For women in the perimenopausal transition, HRT addresses the hormonal driver directly. Adequate sleep, dietary protein, and vitamin C support the biological infrastructure of collagen synthesis. Avoiding smoking and reducing excess sugar address the two most significant dietary and lifestyle accelerators.

Is the "collagen cliff" at menopause reversible?

Partially. HRT started near the onset of perimenopause can both slow the accelerated loss and partially restore collagen that has been lost — the research shows this is more effective in women with moderate rather than severe initial collagen deficiency. Topical retinoids stimulate new collagen synthesis and can produce measurable increases in dermal collagen density. The UV-driven component of collagen loss is largely preventable going forward with daily SPF, though damage already accumulated cannot be reversed by SPF. The earlier interventions begin, the more prophylactic benefit they produce.

The Bottom Line

Collagen decline is inevitable — but the rate at which it happens is substantially modifiable, and in women, the hormonal component is both the most significant driver and the most directly addressable one.

The gradual 1 to 2% annual intrinsic decline is a background process. The 30% loss in the first five years post-menopause is driven by oestrogen deficiency and is the primary target for meaningful intervention. HRT addresses this directly. Daily SPF prevents the UV component. Retinoids stimulate new synthesis. These three interventions together — alongside adequate sleep, protein, and vitamin C — address the principal modifiable drivers of collagen loss across both the intrinsic and hormonal pathways.

Collagen supplements provide a modest additional contribution. They are worth considering as part of a broader approach, particularly for women who have already experienced significant loss and are managing the hormonal component through HRT or other means.

For a structured approach to the lifestyle foundations most relevant to skin and hormonal health through perimenopause, the Perimenopause Reset and Sleep Reset from the Reset Series™ address the two systems most directly connected to collagen health at this life stage.

Related reading: Perimenopause in Your 30s and 40s: Early Symptoms Explained · Are Face Serums Worth the Hype?

Popular Articles